Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

EU plans to boost reach of Pfizer COVID-19 shot

Stock MarketsOct 18, 2021 12:06PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Pharmacist Susanne Wohlgemuth prepares Pfizer/BioNTech COVID-19 vaccinations at the Haus an der Linde nursing home in Lichtentanne, Saxony, Germany December 27, 2020, the day when the country starts its vaccination programme. Hendrik Schmidt/P

By Yadarisa Shabong and Pushkala Aripaka

(Reuters) -Europe's drug regulator said on Monday it was evaluating use of the Pfizer-BioNTech COVID-19 vaccine in children as young as five, while also taking steps to aid an increase in production and boost the shot's reach.

The European Medicines Agency said it would review data, including results from an ongoing study, for the vaccine - known as Comirnaty. It has already been authorised for use in those 12 years of age and older in the European Union and United States.

The two-shot vaccine, based on new mRNA technology, was found to induce a strong immune response in five- to 11-year- olds in a clinical trial of 2,268 participants, the drugmakers said last month.

Pfizer (NYSE:PFE) and German partner BioNTech submitted data on Comirnaty for young children last week.

While children are less susceptible to severe COVID-19, they can spread the coronavirus to others, including those more at risk of severe illness.

Alongside vaccinating children, regulators and drugmakers are also considering booster doses for the vulnerable, underscoring the need to increase production and extend access to protection from the virus to as many people as possible.

The EMA also said on Monday it had approved https://www.ema.europa.eu/en/news/new-manufacturing-sites-new-formulation-approved-covid-19-vaccine-biontech-pfizer two more manufacturing sites for producing the vaccine in the Italian cities of Monza and Anagni, while also giving the green light to a ready-to-use formulation of Comirnaty.

The sites would produce up to 85 million additional doses to suppply the European Union in 2021, the regulator said. Pfizer and BioNTech are the biggest supplier of COVID-19 vaccines to the bloc.

The drugmakers' new approved formulation that does not require dilution would also allow for longer storage and easier transportation at regulator refrigerator temperatures of 2°C to 8°C.

In a statement https://investors.biontech.de/node/10851/pdf, BioNTech said the new formulation for individuals 12 years and older will be available in a phased rollout starting in early 2022.

EU plans to boost reach of Pfizer COVID-19 shot
 

Related Articles

Bitcoin falls 8.4% to $49,228.82
Bitcoin falls 8.4% to $49,228.82 By Reuters - Dec 04, 2021

(Reuters) - Bitcoin dropped 8.4% to $49,228.82 at 20:01 GMT on Saturday, losing $4,514.87 from its previous close. Bitcoin, the world's biggest and best-known cryptocurrency, is...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (3)
Walter Jeffries
Walter Jeffries Oct 18, 2021 12:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You are being lied to people. Time to turn off CNN and MSNBC, wake up and fight back!
Thomas Phantom
Thomas Phantom Oct 18, 2021 12:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looool
Walter Jeffries
Walter Jeffries Oct 18, 2021 12:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Children die from COVID-19 at a rate of 0.0 per hundred thousand. They are not at risk and don't need the vaccine. They are also the most vulnerable to myocarditis, and several other adverse effects that can be fatal.
Felipe Daniel
Felipe Daniel Oct 18, 2021 10:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Crimes against humanity. Violation of Nuremberg Code where it says each human has right over their own body regardless of what collective says.
Thomas Phantom
Thomas Phantom Oct 18, 2021 10:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you cant be serious
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email